Christopher A. Bleck
Director/Board Member at IMAGIN MEDICAL INC.
Net worth: 558 $ as of 29/04/2024
Profile
Christopher A.
Bleck currently works at Imagin Medical, Inc., as Independent Director from 2018.
Mr. Bleck also formerly worked at Incept BioSystems, Inc., as President & Chief Executive Officer in 2011, Intact Medical Corp., as Director, Abbott Laboratories, as Corporate Vice President-Pediatric Products from 1983 to 2001, Cytyc Corp., as VP-Worldwide Marketing & Commercial Operations from 2001 to 2007, Abbott Canada, as President & General Manager from 1983 to 2001, and OvaScience, Inc., as Chief Financial, Operating & Accounting Officer in 2014.
Mr. Bleck received his undergraduate degree and Masters Business Admin degree from the University of Connecticut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMAGIN MEDICAL INC.
0.13% | 20/11/2022 | 13,961 ( 0.13% ) | 558 $ | 29/04/2024 |
Christopher A. Bleck active positions
| Companies | Position | Start |
|---|---|---|
| IMAGIN MEDICAL INC. | Director/Board Member | 01/10/2018 |
Former positions of Christopher A. Bleck
| Companies | Position | End |
|---|---|---|
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director of Finance/CFO | 16/09/2014 |
Incept BioSystems, Inc.
 Incept BioSystems, Inc. BiotechnologyHealth Technology Incept BioSystems, Inc. develops microscale and nanoscale technologies to treat infertility. The company was founded by Michael Crowley, Charlie Covert and Gary D. Smith in 2005 and is headquartered in Ann Arbor, MI. | Chief Executive Officer | 31/05/2011 |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Sales & Marketing | 22/10/2007 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 31/12/2000 |
| Abbott Canada | President | 31/12/2000 |
Training of Christopher A. Bleck
| University of Connecticut | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| IMAGIN MEDICAL INC. | Health Services |
| Private companies | 5 |
|---|---|
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
Incept BioSystems, Inc.
Incept BioSystems, Inc. BiotechnologyHealth Technology Incept BioSystems, Inc. develops microscale and nanoscale technologies to treat infertility. The company was founded by Michael Crowley, Charlie Covert and Gary D. Smith in 2005 and is headquartered in Ann Arbor, MI. | Health Technology |
| Abbott Canada | |
Intact Medical Corp.
 Intact Medical Corp. Medical SpecialtiesHealth Technology Intact Medical Corp. develops and distributes minimally invasive devices for the excision of breast tissue for diagnostic and therapeutic applications. The company founded by Scott P. Huntley and Philip E. Eggers in 1998 and is headquartered in Naples, FL. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Christopher A. Bleck
